PERSONAL DETAIL


Dr. Nur Lisa Binti Zaharan

Department of Pharmacology
Faculty of Medicine
 
  +603-79674703
  +603-79674791
  nurlisazaharan@um.edu.my
  Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, MALAYSIA
 
ResearcherID Link
  http://www.researcherid.com/rid/F-8835-2012


BIBLIOMETRIC DATA


 Total Articles in Publication List  26
 Articles With Citation Data  26
 Sum of the Times Cited   151
 Average Citations per Article   5.81
 h-index   6
 Co-authors   Collaboration Network
 This information is generated from http://researcherid.com

ACADEMIC QUALIFICATION
(Qualification), (Institution).



PROFESSIONAL
(Organisation), (Role), (Year), (Level).


  • Irish Medical Council, Registered Member, 2005 to 2009, (National)
  • UK Drug Utilization Research Group, Registered Member, 2008 to 2011, (International)
  • BRITISH PHARMACOLOGICAL SOCIETY, Associate Member, 2009 to 2010, (International)
  • Malaysian Medical Council, Registered Member, 2012, (National)
  • International Society of Pharmacoepidemiology, Membership, 2016 to 2018, (International)
  • Malaysian Society of Pharmacology And Physiology , Membership, 2018 to 2019, (National)

ADMINISTRATIVE DUTIES
(Role), (Level), (Start date),(End Date).


  • Coordinator, Faculty, 21/06/2018 to 21/06/2019 (Elective MIX3003: Drugs from Target to Market)
  • Coordinator, Faculty, 05/04/2018 to 04/04/2020 (STAGE 2 MBBS (UMMP))
  • Committee Member, Faculty, 13/07/2015 to 07/07/2019 (Representative of Faculty of Medicine, Ethics Committee Faculty of Dentistry, University of Malaya)
  • COORDINATOR MBBS UMMP DEPT OF PHARMACOLOGY, Faculty, 10/12/2013 to 19/04/2018 (UMMP STAGE 2 DEPARTMENT OF PHARMACOLOGY)
  • Ahli Jawatankuasa Ijazah Tinggi (JKIT), Faculty, 15/10/2012 to 12/10/2015
  • PBL PHASE II COORDINATOR- DEPARTMENT OF PHARMACOLOGY, Faculty, 01/07/2011 to 01/07/2013

AREAS OF EXPERTISE
(Area).


  • Clinical Pharmacology
  • Molecular Pharmacology (Pharmacogenomics)
  • Medical and Health Sciences,  (Medical statistics)
  • Medical Pharmacology (Pharmacoepidemiology)


RECENT SELECTED PUBLICATIONS
(Publication).


Chapter in Book

2014
  • Zaharan, N.L and Lee, P.K.2014. Drugs and the Endocrine System. in Chan, Yoo Kuen, Ng, Kwee Peng, Sim, Debra Si Mui (Eds.)Pharmacological Basis of Acute Care, page 131-140. Springer International Publishing Switzerland 
Article in Academic Journals

2018
  • Zaharan NL, Muhamad NH, Jalaludin MY, Su TT, Mohamed Z, Mohamed MNA, Majid HA (2018) Non-synonymous single nucleotide polymorphisms and physical activity interactions on adiposity parameters in Malaysian adolescents. Frontiers in Endocrinology. 9:209. doi: 10.3389/fendo.2018.00209. eCollection 2018 (ISI-Indexed)
  • Venkatason, P., Zaharan, N.L., Ismail, M.D., .,Wan Azman, W.A, Mahmood Zuhdi, A.S. Trends and variations in the prescribing of secondary preventative cardiovascular therapies for patients with Non-ST Elevation Myocardial infarction (NSTEMI) in Malaysia. Eur J Clin Pharmacol 2018 https://doi.org/10.1007/s00228-018-2451-3 (ISI-Indexed)

2017
  • Rahmadhani, R., Zaharan, N. L., Mohamed, Z., Moy, F. M., & Jalaludin, M. Y. (2017). The associations between VDR BsmI polymorphisms and risk of vitamin D deficiency, obesity and insulin resistance in adolescents residing in a tropical country. PLoS One, 12(6), e0178695. doi: 10.1371/journal.pone.0178695 (ISI-Indexed)

2016
  • D. A. Loh, F. M. Moy, N. L. Zaharan, M. Y. Jalaludin and Z. Mohamed. 2016. Sugar-sweetened beverage intake and its associations with cardiometabolic risks among adolescents. Pediatric Obesity. doi:10.1111/ijpo.12108 (ISI-Indexed)
  • R.M. Guad, N.L. Zaharan, Z. Chik, Z. Mohamed, B.S. Haerian, K.P. Ng, W.A.H. Wan Md Adnan. Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients. TRANSPLANTATION PROCEEDINGS 48(1):81-87 FEBRUARY 2016. Impact Factor: 0.98 DOI: 10.1016/j.transproceed.2016.01.001 (ISI-Cited Publication) (ISI-Indexed)
  • Ling JC, Mohamed MN, Jalaludin MY, Rampal S, Zaharan NL, Mohamed Z (2016).Determinants of High Fasting Insulin and Insulin Resistance Among Overweight/Obese Adolescents. Sci Rep 6:36270. (ISI-Indexed)

2015
  • Zain SM, Mohamed Z, Jalaludin MY, Fauzi F, Hamidi A, Zaharan NL. Comprehensive evaluation of the neuropeptide-y gene variants in risk of obesity: A case-control study and meta-analysis. Pharmacogenetics and Genomics. 2015;25(10):501-10 (ISI-Indexed)
  • Loh, D. A., Moy, F. M., Zaharan, N. L., & Mohamed, Z. (2015). Disparities in health-related quality of life among healthy adolescents in a developing country - the impact of gender, ethnicity, socio- economic status and weight status. Child Care Health Dev, 15(10). April 2015. Impact Factor: 1.83 DOI: 10.1111/cch.12252 (ISI-Indexed)

2014
  • Wan Md Adnan WAH, Zaharan NL, Wong MH, Lim SK (2014) The Effects of Intermittent Fasting during the Month of Ramadan in Chronic Haemodialysis Patients in a Tropical Climate Country. PLoS ONE 9(12): e114262. doi:10.1371/journal.pone.0114262 (ISI-Indexed)
  • Zaharan NL , Williams D & Bennett K. 2013. Prescribing of antidiabetic therapies in Ireland: 10-year trends 2003 2012. Ir J Med Sci DOI 10.1007/s11845-013-1011-1 (ISI-Indexed)

2013
  • Loh DA, Moy FM, Zaharan NL, Mohamed Z (2013) Eating Behaviour among Multi-Ethnic Adolescents in a Middle- Income Country as Measured by the Self-Reported Children�s Eating Behaviour Questionnaire. PLoS ONE 8(12): e82885. doi:10.1371/journal.pone.0082885 (ISI-Indexed)
  • Zaharan NL, Williams D, Bennett K 2013. Statins and Risk of Treated Incident Diabetes in a Primary Care Population. Br J Clin Pharmacol.75 (4):1118-1124 (ISI-Indexed)

2011
  • Musleh S, Kraus S, Bennett K, Zaharan NL, 2011. Irish Medicines Board safety warnings: do they affect prescribing rates in primary care? Pharmacoepidemiol Drug Saf 20(9):979-986 (ISI/SCOPUS Indexed Publication)
  • Wan Md Adnan, WAH, Zaharan, NL, Bennett, K and Wall, CA. 2011. Trends in co-prescribing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in Ireland. Br J Clin Pharmacol 71 (3): 458-466 (ISI-Indexed)

2009
  • Zaharan N.L, Mahmud, A, Bennett, K, Feely, J. 2009. Hypertension in Ireland: public awareness and doctors choice of therapy. Ir J Med Sci 178(4):413-7. (ISI-Indexed)
Proceeding

2016
  • Mac Guad, Rhanye; Wan Md Adnan, Wan Ahmad Hafiz; Raja Aziddin, Raja Elina; Mohamed, Zahurin and Zaharan, Nur Lisa.2016. Evaluation of Clinical and Genetic Risk Factors in the Development of New-Onset Diabetes Mellitus in Malaysian Post-renal Transplant Patients. Pharmacoepidemiol Drug Saf 25:S3: 483 (ISI-Indexed)

2015
  • N.H. Muhamad, N.L. Zaharan, A. Hamidi, Z. Mohamed (2015) ADIPOQ rs266792 Polymorphisms and Obesity Related Parameters in Malaysian Adolescents Population. Public Health Genomics;18(suppl 1):1-51 (ISI-Indexed)
  • R.M. Guad, N.L. Zaharan, Z. Chik, Z. Mohamed, B.S. Haerian, K.P. Ng, W.A.H. Wan Md Adnan (2015) Genetic Polymorphism of the Multidrug Resistance-1 in Once-Daily- versus Twice-Daily Tacrolimus Formulations. Public Health Genomics;18(suppl 1):1-51 (ISI-Indexed)
  • N.L. Zaharan, S.M. Zain, A. Hamidi, Z. Mohamed (2015) The Role of NPY rs16147 and rs5574 Polymorphisms on Obesity Parameters and Cardiometabolic Risk Factors in Urban Malaysian Adolescents Public Health Genomics;18(suppl 1):1-51 (ISI-Indexed)

2013
  • Adnan, WAH; Zaharan, NL. 2013. Hyponatraemia predicts 1-year mortality in stable peritoneal dialysis patients. NDT 28 (Supplement 1): 429-429 (ISI-Indexed)

2011
  • Zaharan NL, Williams D, Bennett K (2011). Statins and new onset Diabetes in the Primary Care Population. Basic Clin Pharmacol Toxicol; 109: 140-140 (ISI-Indexed)

2010
  • Zaharan N, Bennett K (2010). Antidepressants and new onset diabetes in the Irish primary care population. Pharmacoepidemiol Drug Saf; 19: 6: 645-649 (ISI-Indexed)
  • Tisdall, A.R, Zaharan, N.L, Wash, O, Murphy, B, Peterkin, A, McDermot, J.H, Bennett, K & Sreenan,S. 2010. Assessment of relationship between patient-reported compliance with medications and cardiovascular risk factors in Type 2 diabetes. Ir J Med Sci 179 (13): 526 (ISI-Indexed)

2009
  • Wan Md Adnan WAH, Zaharan N, Bennett K, Wall CA, Feely J (2009). Patterns of co-prescribing of angiotensin converting enzyme inhibitor and angiotensin receptor blockers in Ireland. Eur J Epidemiol; 24: (Suppl 1): 33 (ISI-Indexed)
  • Zaharan N, Bennett K, Feely J (2009). Variations in Cardiovascular therapies prescribing for patients with diabetes. Pharmacoepidemiol Drug Saf; 18: 1-11. (ISI-Indexed)
  • Zaharan N, Bennett K, Feely J (2009). Utilization of hypoglycaemic agents in newly treated type 2 diabetes patients in Ireland. Pharmacoepidemiol Drug Saf; 18: 1-11. (ISI-Indexed)
  • Zaharan N, Bennett K, Feely J. Prescribing of antidiabetes therapies in Ireland (2009). Eur J Epidemiol; 24: (Suppl 1): 245 (ISI-Indexed)
  • Rakovac, AT, Zaharan, NL, McDermott JH, Bennett K, Sreenan S (2009). Beliefs about medicines affect adherence to medications. Ir J Med Sci; 178 Suppl 10: S382-422 (ISI-Indexed)

2008
  • Zaharan N, Bennett K, Feely J (2008). Primary preventative cardiovascular therapies for diabetes mellitus patients in Ireland. Pharmacoepidemiol Drug Saf; 17: S1�S294. (ISI-Indexed)
  • Zaharan N, Bennett K, Feely J. Corticosteroids Prescribing and Diabetes in Primary Care (2008). Pharmacoepidemiol Drug Saf; 17: S1 S294 (ISI-Indexed)
  • Zaharan N, Bennett K, Feely J (2008). Prescribing of Cardiovascular Therapies in Diabetes Mellitus patients in Primary Care. Pharmacoepidemiol Drug Saf;17:7: 742-750 (ISI-Indexed)
  • Zaharan N, Bennett K, Feely J (2008). Prevalence and Awareness of Hypertension Among General Public in Dublin. Pharmacoepidemiol Drug Saf; 17:7: 742-750 (ISI-Indexed)

AREAS OF RESEARCH
(Project title), (Role), (From)-(Until), (Level), (Source).


  • The role of various Genetic Polymorphisms in Childhood Obesity, Principal Investigator(PI), 2014 - 2014, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Obesity in Malaysian adolescent population: Prevalence, risk factors, complications and intervention, Principal Investigator(PI), 2014 - 2014, High Impact Research (HIR), (National)
  • Obesity In Malaysian Adolescent Population: Prevalence, Risk Factors, Complications And Intervention., Principal Investigator(PI), 2013 - 2016, High Impact Research - Ministry of Education (HIR-MOE) Cycle 3, (National)
  • Genetic Contributions To Adverse Drug Reactions (adr) In The Malaysian Population: Focus On Calcineurin Inhibitor Nephrotoxicity (cnit), Consultant, 2013 - 2018, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)

AWARDS AND RECOGNITIONS
(Name of Award), (Awarding Institution), (Year Awarded), (Level).


  • Excellence Service Award, University Malaya, 2015, (University)
  • Best Poster Prize (Third Place)- Golden Helix Pharmacogenomics Symposium, Kuala Lumpur for Poster Presentation Entitled The Role of Npy Rs16147 and Rs5574 Polymorphisms On Obesity Parameters and Cardiometabolic Risk Factors in Urban Malaysian Adolescents, Golden Helix, 2015, (International)
  • Certificate of Excellent Service, University Malaya, 2014, (University)
  • Sijil Perkhidmatan Cemerlang, University Malaya, 2014, (University)
  • Best Paper Published in The Irish Journal of Medical Science 2011 Awarded This Prize by The Royal Academy of Medicine Ireland (Rami) for The Paper Published in The Irish Journal of Medical Science Entitled �Hypertension in Ireland: Public Awareness and Doctors Choice of Therapy�, Royal Academy of Medicine Ireland, 2011, (International)
  • Best Poster Presentation: Awarded This Prize At Uk Drug Utilization Research Group (Ukdurg) 20th Annual General Meeting for Poster Presentation Entitled �Prescribing of Cardiovascular Therapies in Diabetes Mellitus Patients in Primary Care�, Uk Drug Utilization Research Group, 2008, (International)
  • Ucd Scholarship Award for Fifth Year of Medicine, University College Dublin, 2003, (University)
  • Dillon Memorial Prize Awarded This Prize by National University of Ireland (University College Dublin) for Obtaining The Highest Honours in Pharmacology Subject., University College Dublin, 2002, (University)

PRESENTATIONS
(Title), (Event), (Date Presented), (Organiser), (Level).


INVITED SPEAKER
  • A statin a day to keep the cardiologist away: Lessons from randomized clinical trials and observational studies, Faculty of Medicine Research Week , 2015-05-14 to 2015-05-14, Department of Pharmacology and Department of Pharmacy, Faculty of Medicine, University of Malaya, (University)
ORAL
  • Cardiovascular prescribing for patients with diabetes in primary care population.(Finalist), Jacqueline Horgan Bronze Medal Prize, 2008-11-13 to 2008-11-13, Royal Academy of Medicine, Ireland, (National)
  • Prescribing of Antidiabetes Therapies In Ireland, 2009 British Pharmacological Society Summer Meeting, 2009-07-08 to 2009-07-10, British Pharmacological Society, (International)
  • The Role of Adiponectin Gene Polymorphism in Childhood Obesity , Malaysian Society of Pharmacology and Physiology conference, 2012-05-18 to 2012-05-20, Malaysian Society of Pharmacology and Physiology conference, (National)
  • HLA Class II Antigen Mismatch and 1-year biopsy proven acute rejection, Pharmacology & Physiology International Scientific Congress 2014, 2014-08-23 to 2014-08-24, Malaysian Society of Pharmacology & Physiology, (International)
  • The association between CYP3A5 polymorphisms and dose-adjusted trough level and dosage requirement of two tacrolimus formulations in post-renal transplant patients, 18th Scientific Meeting of the Malaysian Society of Transplantation, 2015-06-05 to 2015-06-06, Malaysian Society of Transplantation, (National)
POSTER
  • Hyponatraemia predicts 1-year mortality in stable peritoneal dialysis patients., 50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress, 2013-05-18 to 2013-05-21, European-Renal-Association and European-Dialysis-and-Transplant-Association, (International)
  • Hyponatraemia predicts 1-year mortality in stable peritoneal dialysis patients , 50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress, 2013-05-18 to 2013-05-21, European Renal Association & European Dialysis and Transplant Association, (International)
  • Classification of physical fitness index (PFI using modified Harvard step test (MHST) & relationship between PFI and body mass index(BMI)among overweight/obese adolescents in Kuala Lumpur, Malaysia , 13th Asian Federation of Sports Medicine Congress , 2013-09-25 to 2013-09-28, Asian Federation of Sports Medicine, (International)
  • Adiposity Measures in Hypertensive population, Malaysian Society of Hypertension-11th Annual Scientific Meeting, 2014-01-17 to 2014-01-19, Malaysian Society of Hypertension, (National)
  • Evaluation of central obesity in Malaysian adolescent population; prospective cross-sectional study , 12th International Congress of Obesity, 2014-03-17 to 2014-03-19, World obesity, (International)
  • Correlation between anthropometric measures and cardiometabolic risk factors in urban Malaysian adolescent , 12th International Congress of Obesity, 2014-03-17 to 2014-03-19, World Obesity, (International)
  • Prevalence of obesity and cardiometabolic risk factors in young urban adolescents in Malaysia, 12th International Congress of Obesity, 2014-03-17 to 2014-03-19, World Obesity, (International)
  • ADIPOQ rs266792 Polymorphisms and Obesity Related Parameters in Malaysian Adolescents Population, 2015 Golden Helix Pharmacogenomics Symposium, 2015-03-12 to 2015-03-13, Golden Helix Association and Pharmacogenomics Lab, University Malaya, (International)
  • The Role of NPY rs16147 and rs5574 Polymorphisms on Obesity Parameters and Cardiometabolic Risk Factors in Urban Malaysian Adolescents, 2015 Golden Helix Pharmacogenomics Symposium, 2015-03-12 to 2015-03-13, Golden Helix Association and Pharmacogenomics Lab, University Malaya, (International)
  • Genetic Polymorphism of the Multidrug Resistance-1 in Once-Daily- versus Twice-Daily Tacrolimus Formulations., 2015 Golden Helix Pharmacogenomics Symposium, 2015-03-12 to 2015-03-13, Golden Helix Association and Pharmacogenomics Lab, University Malaya, (International)
  • VDR polymorphisms and its association with obesity parameters, cardiometabolic risk factors and Vitamin D status in Malaysian urban adolescents, Faculty of Medicine Research Week. , 2015-05-11 to 2015-05-15, Department of Pharmacology & Department of Pharmacy, University of Malaya, (University)
  • FTO polymorphisms and its association with obesity-related traits and cardiometabolic risk factors in multi-ethnic Malaysian adolescents. , Faculty of Medicine Research Week., 2015-05-11 to 2015-05-15, Department of Pharmacology and Department of Pharmacy, Faculty of Medicine, University of Malaya, (University)

EXPERT LINKAGES
(Linkages Description), (Organisation), (Year of Involvement), (Duration), (Level).


  • Host to Research Elective Program, University of Leeds, 2018, 3, (University)

EXPERT/TECHNICAL CONTRIBUTIONS
(Activity), (Organisation), (Role), (From)-(Until), (Level).


  • Faculty of Medicine Research Week �From Powder to Pills, From Pills to Heal�,11-15th May 2015, Department of Pharmacology and Pharmacy, Committee Member, 2015-2015, (University)
  • Interview panel for Program Biasiswa Yang Di-Pertuan Agong Sesi pengajian 2015/2016., Jabatan Perkhidmatan Awam (JPA), Interview Panel, 2015-2015, (National)
  • Committee member for the 2015 Golden Helix Symposium-Next generation Pharmacogenomics. 11th-13th March 2015, Golden Helix Foundation and Pharmacogenomics Lab, University Malaya, Committee Member, 2015-2015, (International)
  • Trainer for Discover Your Soft Skills @ University Malaya (iCONS), Student Empowerment & Research Unit (SERU), Resource Person, 2014-2017, (University)
  • Facilitator and Resource person for Prescribing Skills Training Workshop, Prescribing Initiatives for Life-Long Learning Skills (PILLS), Resource Person, 2011-2014, (University)

EVALUATION ACTIVITIES
(Description), (Evaluation Activity),(Year).


  • European Journal of Clinical Pharmacology, Article In Journal ,  (2018 - 2018)
  • Journal of Diabetes, Article In Journal ,  (2018 - 2018)
  • European Journal of Clinical Pharmacology, Article In Journal ,  (2017 - 2017)
  • Pharmacoepidemiology and Drug Safety, Article In Journal ,  (2016 - 2016)
  • BMC Infectious Disease, Article In Journal ,  (2016 - 2016)
  • British Journal Clinical Pharmacology, Article In Journal ,  (2016)
  • Journal of Diabetes, Article In Journal ,  (2016)
  • European Journal of Clinical Pharmacology, Article In Journal ,  (2016)
  • The impact of genetic polymorphisms in cabdidatr genes on susceptibility to epilepsy and responsiveness to antiepileptic treatment. Miss Hidayati Mohd Sha'ari. MSc. University of Malaya, Thesis ,  (2015 - 2015)
  • Journal of Diabetes, Article In Journal ,  (2015 - 2015)
  • The Impact of Single Nucleotide Polymorphisms, Cytokine Function and MicroRNA Regulation on Susceptibility to Preterm Birth. Mrs Immaculate Mbonge. PhD. University of Malaya. 28th January 2015, Candidature Defence ,  (2015 - 2015)
  • The Impact of Single Nucleotide Polymorphisms, Cytokine and MicroRNA profiling on Susceptibility to Preterm Birth.Mrs Immaculate Mbonge Lamia. PhD. University of Malaya, Thesis ,  (2015 - 2015)
  • European Journal of Clinical Pharmacology, Article In Journal ,  (2015 - 2015)
  • Miss Hidayati Mohd Sha�ari. Pharmacogenomics of Epilepsy. 24th February 2015. MSc. University of Malaya, Candidature Defence ,  (2015 - 2015)
  • Journal of Diabetes, Article In Journal ,  (2015 - 2015)
  • Determinant of Access to Medicines in Children Living in Poor Households of Peninsular Malaysia. Miss Asmalita binti Syaiful.MSc. Islamic Sciences University of Malaysia (USIM), Thesis ,  (2015 - 2015)
  • European Journal of Clinical Pharmacology, Article In Journal ,  (2014 - 2014)
  • British Journal of Clinical Pharmacology, Article In Journal ,  (2014 - 2014)
  • Value in Health, Article In Journal ,  (2014 - 2014)
  • Molecular analysis of various candidate genes with lymphoproliferative disorders and their association with methotrexate related toxicities in the Malay, Chinese and Indian ethnic groups of the Malaysian population. Miss Sujatha a/p Suthandiram. PhD. University of Malaya. 14th February 2014, Candidature Defence ,  (2014 - 2014)
  • Diabetes Research & Clinical Practice, Article In Journal ,  (2013 - 2014)
  • The association of candidate genes with metabolic syndrome and weight changes in schizophrenia patients on antipsychotic treatment. Miss Norshuhada Mohd Roffeei. MSc. University of Malaya, Thesis ,  (2013 - 2013)
  • European Journal of Clinical Pharmacology, Article In Journal ,  (2013 - 2013)
  • Drugs & Aging journal, Article In Journal ,  (2013 - 2013)
  • Gene expression and association analyses of HT2A and LIM (PDLIM5) in bipolar disorder. Mr Mohd Aizat Mohd Zain.MSc. University of Malaya30th June 2011, Candidature Defence ,  (2011 - 2011)

CONTRIBUTION TO SOCIETY
(Contribution To Society), (Level), (Start Date), (End Date).


  • Development of mobile apps 'Calorie Traffic' for monitoring caloric intake based on Malaysian local food, (Community), 24/08/2015 until  
  • Development of interactive website for educating adolescents on healthy lifestyles to manage their body weight www.myhealthyyouth.com.my, (Community), 01/08/2015 until  
  • Trainer for Discover Your Soft Skills @ University Malaya. , (University), 01/03/2014 until 01/03/2017

SUPERVISION


FIRST DEGREE/DIPLOMA/PRE-DEGREE
(Course Title), (Academic Session), (No. of Candidates)

Completed
  • Anthropometric predictors of cardiovascular risk in hypertensive patients, 2013/2014, 3
  • Hyponatraemia predicts one year mortality in stable peritoneal dialysis patients, 2013/2014, 1
  • Association of single nucleotide polymorphism (SNPs) in ADIPOQ and FTO gene with childhood obesity. Miss Sandee Tun. BSc. University of Malaya, 2011/2012, 1
  • Weight problem and its lifestyle risk factors amongst university students, 2011/2012, 5
POST GRADUATE STUDENT
(Name of Degree), (Name of Candidates), (Title of Thesis), (Academic Session)

Ongoing
  • Master Degree, Nor Hanisah Muhamad, 3.The Role Of Non-synonymous Single Nucleotide Polymorphisms In Obesity And Morbid Obesity Amongst Malaysian Adolescents, 2015/2016
  • Doctoral Degree (phd), Anahita Hamidi, association of obesity-related gene variants with clinical and metabolic complications of obesity in malaysian paediatrics population, 2012/2013
  • Master Degree, Rayinda Rahmadhani, The role of various genetic polymorphism in childhood obesity, 2011/2012

TEACHING
(Course Title), (Academic Session), (No of Student), (No of Contact Hours).


FIRST DEGREE
  • Pharmacology Phase IIIb, 2014/2015, 202, 6
  • Pharmacology Phase II, 2014/2015, 2, 11
  • Pharmacology Phase IIIa, 2014/2015(1), 202, 1
  • ADVANCED MEDICAL PHARMACOLOGY, 2014/2015(2), 5, 7
  • Pharmacology Stage I, 2014/2015(1,2), 124, 41.5
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2014/2015(1), 58, 3
  • FARMAKOLOGI, 2014/2015(1,2), 48, 11.5
  • PHARMACOLOGY AND HANDLING OF MEDICATION, 2014/2015(2), 16, 2
  • PRINCIPLES OF DRUG ACTION & PERIPHERAL NERVOUS SYSTEM, 2014/2015(1), 69, 6
  • Pharmacology Stage II, 2014/2015, 172, 32.5
  • PHARMACOLOGY AND HANDLING OF MEDICATION, 2013/2014(1,2), 16, 2
  • Pharmacology Phase IIIb, 2013/2014, 180, 18
  • Pharmacology Phase IIIa, 2013/2014(1,2), 210, 1
  • FARMAKOLOGI, 2013/2014(1,2), 72, 8
  • Pharmacology Phase II, 2013/2014, 204, 21
  • PRINCIPLES OF DRUG ACTION & PERIPHERAL NERVOUS SYSTEM, 2013/2014(1,2), 50, 6
  • Pharmacology Stage I, 2013/2014, 178, 45.5
  • BASIC MEDICAL SCIENCE III, 2012/2013, 25, 4
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2012/2013, 73, 3
  • PRINCIPLES OF DRUG ACTION & PERIPHERAL NERVOUS SYSTEM, 2012/2013(2), 81, 6
  • Pharmacology Phase II, 2012/2013, 210, 39
  • Doctor, Patient, Health and Society Phase II, 2012/2013(1,2), 210, 4
  • PHARMACOLOGY, 2012/2013, 69, 22.5
  • Pharmacology Phase II, 2011/2012, 217, 43
  • PHARMACOLOGY, 2011/2012, 69, 20.5
  • Pharmacology Phase IIIb, 2011/2012, 178, 9
  • Doctor, Patient, Health and Society Phase II, 2011/2012, 20, 4
  • ADVANCED MEDICAL PHARMACOLOGY, 2011/2012(2), 6, 4
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2011/2012(1), 70, 3
  • Pharmacology Phase IIIa, 2011/2012, 200, 1
  • PRINCIPLES OF DRUG ACTION & PERIPHERAL NERVOUS SYSTEM, 2010/2011(2), 66, 3
  • Pharmacology Phase II, 2010/2011, 205, 4
  • Pharmacology Phase IIIb, 2010/2011, 175, 4
  • ADVANCED MEDICAL PHARMACOLOGY, 2010/2011(2), 30, 7